
Medicines with the highest expenditure in the Netherlands 2021
In 2020, rivaroxaban, also sold under the brand name Xarelto and used to treat deep vein thrombosis and pulmonary embolism, was the medicine with the highest expenditure in the Netherlands in 2021. The expenditure for this drug amounted to 109 million euros.